Open AccessAB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer
Author(s) -
Μαρία Παπαθανασίου,
Sofia Lambaki,
Κonstantinos Porpodis,
Dionysios Spyratos,
Stavros Τryfon,
Paulos Zarogoulidis,
Ellada Eleytheriadoy,
Theodoros Kontakiotis
Publication year - 2016
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2016.ab036
Subject(s) - afatinib , erlotinib , gefitinib , epidermal growth factor receptor , cancer research , medicine , lung cancer , oncology , epidermal growth factor , erlotinib hydrochloride , cancer , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom